Does Fascin Expression in Diffuse Large B-Cell Lymphomas have a Clinical Impact in Patients Treated with Anthracyclin-Based Chemotherapy Plus Rituximab?

Ayberk BESEN; Fatih KOSE; Fazilet KAYASELCUK; Huseyin MERTSOYLU; Ilhan TUNCER; Naz?m E. KOCER; Ozgur OZYILKAN

首页> 外文期刊>International Journal of Hematology and Oncology >Does Fascin Expression in Diffuse Large B-Cell Lymphomas have a Clinical Impact in Patients Treated with Anthracyclin-Based Chemotherapy Plus Rituximab?

【24h】

Does Fascin Expression in Diffuse Large B-Cell Lymphomas have a Clinical Impact in Patients Treated with Anthracyclin-Based Chemotherapy Plus Rituximab?

机译：Fascin在弥漫性大B细胞淋巴瘤中的表达是否对基于蒽环素的化学疗法加利妥昔单抗治疗的患者产生临床影响？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Hematology and Oncology》 |2016年第4期|共页
作者
Ayberk BESEN; Fatih KOSE; Fazilet KAYASELCUK; Huseyin MERTSOYLU; Ilhan TUNCER; Naz?m E. KOCER; Ozgur OZYILKAN;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Does Fascin Expression in Diffuse Large B-Cell Lymphomas have a Clinical Impact in Patients Treated with Anthracyclin-Based Chemotherapy Plus Rituximab? [J] . Nazym E. KOCER, Fatih KOSE, Fazilet KAYASELCUK, International Journal of Hematology and Oncology . 2018,第2期

机译：Fascin在弥漫性大B细胞淋巴瘤中的表达是否对基于蒽环素的化学疗法加利妥昔单抗治疗的患者产生临床影响？
2. Does Fascin Expression in Diffuse Large B-Cell Lymphomas have a Clinical Impact in Patients Treated with Anthracyclin-Based Chemotherapy Plus Rituximab? [J] . Ayberk BESEN, Fatih KOSE, Fazilet KAYASELCUK, International Journal of Hematology and Oncology . 2016,第4期

机译：Fascin在弥漫性大B细胞淋巴瘤中的表达是否对基于蒽环素的化学疗法加利妥昔单抗治疗的患者产生临床影响？
3. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma [J] . Lee Gyeong-Won, Go Se-Il, Kim Seok-Hyun, Leukemia and lymphoma . 2015,第4期

机译：利妥昔单抗-环磷酰胺，阿霉素，长春新碱和泼尼松联合化疗治疗原发性鼻窦道弥漫性大B细胞淋巴瘤的临床结果和预后：一项改善淋巴瘤存活率的研究
4. Clinical significance and expression of microRNA-21 in diffuse large B-cell lymphoma cell lines and serum of patients [C] . CHEN Wei-qun, LU Honf-da, KONG De-yong, 2011 Asia-Pacific Conference of tumor biology and medicine . 2011

机译：患者弥漫性大B细胞淋巴瘤细胞株和血清中microRNA-21的表达及临床意义
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab–CHOP [O] . Jung Yong Hong, Kyung Ju Ryu, Chaehwa Park, 2017

机译：利妥昔单抗-CHOP治疗弥漫性大B细胞淋巴瘤患者血清survivin阳性和EBV编码RNA组织表达的临床影响
7. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP [O] . Jung Yong Hong, Kyung Ju Ryu, Chaehwa Park, 2017

机译：血清Survivin阳性促进剂阳性B型RNA在瘤镰刀弥漫性大型B细胞淋巴瘤患者中的临床影响

Does Fascin Expression in Diffuse Large B-Cell Lymphomas have a Clinical Impact in Patients Treated with Anthracyclin-Based Chemotherapy Plus Rituximab?

著录项

相似文献

相关主题

期刊订阅